![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 35087 |
FusionGeneSummary for SND1_LEP |
![]() |
Fusion gene information | Fusion gene name: SND1_LEP | Fusion gene ID: 35087 | Hgene | Tgene | Gene symbol | SND1 | LEP | Gene ID | 27044 | 3952 |
Gene name | staphylococcal nuclease and tudor domain containing 1 | leptin | |
Synonyms | TDRD11|Tudor-SN|p100 | LEPD|OB|OBS | |
Cytomap | 7q32.1 | 7q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | staphylococcal nuclease domain-containing protein 1EBNA2 coactivator p100testis tissue sperm-binding protein Li 82Ptudor domain-containing protein 11 | leptinleptin (murine obesity homolog)leptin (obesity homolog, mouse)obese proteinobese, mouse, homolog ofobesity factor | |
Modification date | 20180523 | 20180527 | |
UniProtAcc | Q7KZF4 | P41159 | |
Ensembl transtripts involved in fusion gene | ENST00000354725, ENST00000467238, | ENST00000308868, | |
Fusion gene scores | * DoF score | 13 X 14 X 7=1274 | 1 X 1 X 1=1 |
# samples | 20 | 1 | |
** MAII score | log2(20/1274*10)=-2.67129337248158 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: SND1 [Title/Abstract] AND LEP [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | LEP | GO:0001525 | angiogenesis | 19910644|21771332 |
Tgene | LEP | GO:0001890 | placenta development | 17957153 |
Tgene | LEP | GO:0001936 | regulation of endothelial cell proliferation | 11460888 |
Tgene | LEP | GO:0010507 | negative regulation of autophagy | 25060689 |
Tgene | LEP | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 24340098 |
Tgene | LEP | GO:0032008 | positive regulation of TOR signaling | 25060689 |
Tgene | LEP | GO:0032310 | prostaglandin secretion | 19688109 |
Tgene | LEP | GO:0032814 | regulation of natural killer cell activation | 12504075 |
Tgene | LEP | GO:0032817 | regulation of natural killer cell proliferation | 12504075 |
Tgene | LEP | GO:0042102 | positive regulation of T cell proliferation | 25060689 |
Tgene | LEP | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 12504075 |
Tgene | LEP | GO:0043410 | positive regulation of MAPK cascade | 24340098 |
Tgene | LEP | GO:0044320 | cellular response to leptin stimulus | 17344214 |
Tgene | LEP | GO:0045765 | regulation of angiogenesis | 11460888 |
Tgene | LEP | GO:0046325 | negative regulation of glucose import | 24340098 |
Tgene | LEP | GO:0046427 | positive regulation of JAK-STAT cascade | 17344214 |
Tgene | LEP | GO:0048639 | positive regulation of developmental growth | 17957153 |
Tgene | LEP | GO:0050892 | intestinal absorption | 24340098 |
Tgene | LEP | GO:0050999 | regulation of nitric-oxide synthase activity | 15899045 |
Tgene | LEP | GO:0051726 | regulation of cell cycle | 17344214 |
Tgene | LEP | GO:0072604 | interleukin-6 secretion | 19688109 |
Tgene | LEP | GO:0072606 | interleukin-8 secretion | 19688109 |
Tgene | LEP | GO:1900015 | regulation of cytokine production involved in inflammatory response | 19688109 |
Tgene | LEP | GO:1900745 | positive regulation of p38MAPK cascade | 24340098 |
Tgene | LEP | GO:1990051 | activation of protein kinase C activity | 24340098 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | PRAD | TCGA-HC-8264-01B | SND1 | chr7 | 127347701 | + | LEP | chr7 | 127892044 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000354725 | ENST00000308868 | SND1 | chr7 | 127347701 | + | LEP | chr7 | 127892044 | + |
intron-5UTR | ENST00000467238 | ENST00000308868 | SND1 | chr7 | 127347701 | + | LEP | chr7 | 127892044 | + |
Top |
FusionProtFeatures for SND1_LEP |
![]() |
Hgene | Tgene |
SND1 | LEP |
Functions as a bridging factor between STAT6 and thebasal transcription factor. Plays a role in PIM1 regulation of MYBactivity. Functions as a transcriptional coactivator for theEpstein-Barr virus nuclear antigen 2 (EBNA2).{ECO:0000269|PubMed:7651391}. | Key player in the regulation of energy balance and bodyweight control. Once released into the circulation, has centraland peripheral effects by binding LEPR, found in many tissues,which results in the activation of several major signalingpathways (PubMed:17344214, PubMed:15899045, PubMed:19688109). Inthe hypothalamus, acts as an appetite-regulating factor thatinduces a decrease in food intake and an increase in energyconsumption by inducing anorexinogenic factors and suppressingorexigenic neuropeptides, also regulates bone mass and secretionof hypothalamo-pituitary-adrenal hormones. In the periphery,increases basal metabolism, influences reproductive function,regulates pancreatic beta-cell function and insulin secretion, ispro-angiogenic for endothelial cell and affects innate andadaptive immunity (By similarity) (PubMed:8589726,PubMed:11460888, PubMed:19688109, PubMed:24340098,PubMed:25060689). In the arcuate nucleus of the hypothalamus,activates by depolarization POMC neurons inducing FOS and SOCS3expression to release anorexigenic peptides and inhibits byhyperpolarization NPY neurons inducing SOCS3 with a consequentreduction on release of orexigenic peptides (By similarity). Inaddition to its known satiety inducing effect, has a modulatoryrole in nutrient absorption. In the intestine, reduces glucoseabsorption by enterocytes by activating PKC and leading to asequential activation of p38, PI3K and ERK signaling pathwayswhich exerts an inhibitory effect on glucose absorption(PubMed:24340098). Acts as a growth factor on certain tissues,through the activation of different signaling pathways increasesexpression of genes involved in cell cycle regulation such asCCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1pathways (By similarity) (PubMed:17344214). May also play anapoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5expression (PubMed:18242580). Pro-angiogenic, has mitogenicactivity on vascular endothelial cells and plays a role in matrixremodeling by regulating the expression of matrixmetalloproteinases (MMPs) and tissue inhibitors ofmetalloproteinases (TIMPs) (PubMed:11460888). In innate immunity,modulates the activity and function of neutrophils by increasingchemotaxis and the secretion of oxygen radicals. Increasesphagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells(PubMed:12504075). Plays a pro-inflammatory role, in synergy withIL1B, by inducing NOS2 wich promotes the production of IL6, IL8and Prostaglandin E2, through a signaling pathway that involvesJAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38 (PubMed:15899045,PubMed:19688109). In adaptive immunity, promotes the switch ofmemory T-cells towards T helper-1 cell immune responses (Bysimilarity). Increases CD4(+)CD25(-) T-cell proliferation andreduces autophagy during TCR (T-cell receptor) stimulation,through MTOR signaling pathway activation and BCL2 up-regulation(PubMed:25060689). {ECO:0000250|UniProtKB:P41160,ECO:0000250|UniProtKB:P50596, ECO:0000269|PubMed:11460888,ECO:0000269|PubMed:12504075, ECO:0000269|PubMed:15899045,ECO:0000269|PubMed:17344214, ECO:0000269|PubMed:18242580,ECO:0000269|PubMed:19688109, ECO:0000269|PubMed:24340098,ECO:0000269|PubMed:25060689, ECO:0000269|PubMed:8589726,ECO:0000305|PubMed:15122202, ECO:0000305|PubMed:25232147}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SND1_LEP |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SND1_LEP |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
SND1 | IKBKE, SNW1, RBPJ, GTF2E2, GTF2E1, MYB, PIM1, STAT6, POLR2A, USP22, PDPK1, PRKAA1, UBA5, LZTR1, DHX9, CREBBP, RBM39, SIRT7, CUL3, CDK2, CAND1, APP, RPS3, HNRNPM, TOMM22, RPL19, MYBBP1A, SMNDC1, RPS20, NENF, RPL4, VDAC2, ILF2, SRSF3, HNRNPU, RPN1, HNRNPR, SSR3, FN1, VCAM1, CSNK2A1, ITGA4, G3BP1, PRPF8, RNU1-1, RNU2-1, RNU4-1, RNU6-1, RNU5A-1, MAK, TARDBP, EIF3CL, RPS11, RPS2, RPS6, RPS9, DDX3X, RPL23A, RPL35, RPS16, RPS26, RPS27, RPS3A, SHFM1, LIN28A, HUWE1, RAPGEF2, MDM2, CUL7, OBSL1, CCDC8, UBE2I, ESR1, MMP28, TDRD3, TXNDC5, NTRK1, NPM1, RPL10, CNOT1, MCM2, U2AF2, CDH1, PTP4A1, MTDH, PA2G4, TRAP1, ANXA5, SNRPB2, EIF5B, GPI, IDH2, PDIA3, UBE2N, MRPL12, CRNN, ZNF207, CPNE3, CS, PYGL, SF3A3, DNAJC8, PLS3, CPSF6, NANS, SF3A1, ECHS1, SRP68, MYL12B, AIMP1, CYLD, DLD, DLST, PDHA1, SOD1, TRIM25, BRCA1, YAP1 | LEP | A2M |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SND1_LEP |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SND1_LEP |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SND1 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | SND1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | LEP | C0028754 | Obesity | 13 | CTD_human;HPO |
Tgene | LEP | C0038358 | Gastric ulcer | 6 | CTD_human |
Tgene | LEP | C0011570 | Mental Depression | 5 | PSYGENET |
Tgene | LEP | C0011581 | Depressive disorder | 5 | PSYGENET |
Tgene | LEP | C0043094 | Weight Gain | 5 | CTD_human |
Tgene | LEP | C0015695 | Fatty Liver | 4 | CTD_human |
Tgene | LEP | C0020538 | Hypertensive disease | 4 | CTD_human |
Tgene | LEP | C0236663 | Alcohol withdrawal syndrome | 3 | PSYGENET |
Tgene | LEP | C0020505 | Hyperphagia | 2 | CTD_human;HPO |
Tgene | LEP | C0020619 | Hypogonadism | 2 | CTD_human;HPO |
Tgene | LEP | C0021655 | Insulin Resistance | 2 | CTD_human |
Tgene | LEP | C0023893 | Liver Cirrhosis, Experimental | 2 | CTD_human |
Tgene | LEP | C0028756 | Obesity, Morbid | 2 | CTD_human |
Tgene | LEP | C0033975 | Psychotic Disorders | 2 | PSYGENET |
Tgene | LEP | C0036341 | Schizophrenia | 2 | PSYGENET |
Tgene | LEP | C0524620 | Metabolic Syndrome X | 2 | CTD_human |
Tgene | LEP | C0556385 | Craving for alcohol | 2 | PSYGENET |
Tgene | LEP | C3554224 | LEPTIN DEFICIENCY OR DYSFUNCTION | 2 | ORPHANET;UNIPROT |
Tgene | LEP | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | LEP | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Tgene | LEP | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | LEP | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Tgene | LEP | C0010346 | Crohn Disease | 1 | CTD_human |
Tgene | LEP | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Tgene | LEP | C0019337 | Heroin Dependence | 1 | CTD_human |
Tgene | LEP | C0020443 | Hypercholesterolemia | 1 | CTD_human |
Tgene | LEP | C0020459 | Hyperinsulinism | 1 | CTD_human;HPO |
Tgene | LEP | C0021361 | Female infertility | 1 | CTD_human |
Tgene | LEP | C0021368 | Inflammation | 1 | CTD_human |
Tgene | LEP | C0027746 | Nerve Degeneration | 1 | CTD_human |
Tgene | LEP | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Tgene | LEP | C0032617 | Polyuria | 1 | CTD_human |
Tgene | LEP | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | LEP | C0033687 | Proteinuria | 1 | CTD_human |
Tgene | LEP | C0036572 | Seizures | 1 | CTD_human |
Tgene | LEP | C0039231 | Tachycardia | 1 | CTD_human |
Tgene | LEP | C0085207 | Gestational Diabetes | 1 | CTD_human |
Tgene | LEP | C0085602 | Polydipsia | 1 | CTD_human |
Tgene | LEP | C0149745 | Oral Ulcer | 1 | CTD_human |
Tgene | LEP | C0221765 | Chronic schizophrenia | 1 | PSYGENET |
Tgene | LEP | C0241910 | Hepatitis, Autoimmune | 1 | CTD_human |
Tgene | LEP | C0349204 | Nonorganic psychosis | 1 | PSYGENET |
Tgene | LEP | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Tgene | LEP | C0993582 | Arthritis, Experimental | 1 | CTD_human |
Tgene | LEP | C1262477 | Weight decreased | 1 | CTD_human |
Tgene | LEP | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
Tgene | LEP | C1458155 | Mammary Neoplasms | 1 | CTD_human |